• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Moves Higher; US Crude Stocks Drop More than Projected

    6/28/23 12:22:58 PM ET
    $ASTS
    $CGTX
    $KLR
    $NERV
    Telecommunications Equipment
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ASTS alert in real time by email

    U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 80 points on Wednesday.

    The Dow traded down 0.42% to 33,784.59 while the NASDAQ rose 0.63% to 13,640.83. The S&P 500, also fell, dropping, 0.01% to 4,378.08.

    Check This Out: Top 4 Materials Stocks That Could Sink Your Portfolio In June

     

    Leading and Lagging Sectors

    • Communication services shares jumped by 0.7% on Wednesday.
    • In trading on Wednesday, utilities shares fell by 1.2%.

     

    Top Headline

    U.S. crude oil inventories dropped by 9.603 million barrels in the week ending June 23, versus market estimates of a 1.757 million decline.

     

    Equities Trading UP

    • Kaleyra, Inc. (NYSE:KLR) shares shot up 39% to $6.69 after Tata Communications Limited announced it has entered an agreement to acquire the company.
    • Shares of Minerva Neurosciences, Inc. (NASDAQ:NERV) got a boost, shooting 56% to $9.37. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.
    • Theriva Biologics, Inc. (NASDAQ:TOVX) shares were also up, gaining 32% to $1.0899 after the company announced FDA orphan drug designation to VCN-01 for pancreatic cancer.

     

    Equities Trading DOWN

    • AST SpaceMobile, Inc. (NASDAQ:ASTS) shares dropped 27% to $4.65 after the company announced pricing of an upsized offering of Class A common stock.
    • Shares of Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) were down 20% to $0.5373 after announcing $2.25 million registered direct offering of 5 million at $0.45/share.
    • Cognition Therapeutics, Inc. (NASDAQ:CGTX) was down, falling 20% to $1.9980 after the company released topline data from Phase 2 SEQUEL Study Of CT1812 in 16 adults with mild-to-moderate Alzheimer's disease.

    Also Check This Out: General Mills Likely To Report Lower Q4 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

     

    Commodities

    In commodity news, oil traded up 1.2% to $68.52 while gold traded down 0.5% at $1,915.00.

    Silver traded down 1.1% to $22.715 on Wednesday while copper fell 1.8% to $3.7210.

     

    Euro zone

    European shares were higher today. The eurozone’s STOXX 600 rose 0.75%, London’s FTSE 100 rose 0.59% while Spain’s IBEX 35 Index rose 0.96% The German DAX gained 0.85% French CAC 40 rose 0.98% and Italy’s FTSE MIB Index rose 0.82%.

    Bank lending to households in the Eurozone rose by 2.1% year-over-year to EUR 6.87 trillion in May. German GfK Consumer Climate Indicator fell to a reading of -25.4 heading into July versus a revised level of -24.4 in the earlier month.

    Industrial producer prices in Italy dropped by 4.3% year-over-year in May, while annual inflation rate in Italy eased to 6.4% in June, the lowest in fourteen months. Retail sales in Spain climbed by 6% year-over-year in May, while consumer confidence indicator in France rose to 85 in June from 83 in the prior month.

     

    Asia Pacific Markets

    Asian markets closed mostly higher on Wednesday, with Japan’s Nikkei 225 jumping 2.02%, Hong Kong’s Hang Seng Index gaining 0.12%, China’s Shanghai Composite Index slipping 0.01%. India’s S&P BSE Sensex jumped 1.6%.

    Profits earned by China's industrial firms dipped by 18.8% year-over-year to CNY 2,668.89 billion during the first five months of the year.

     

    Economics

    • Mortgage applications in the U.S. increased 3% in the week ended June 23, 2023.
    • The U.S. trade deficit in goods shrank to $91.1 billion in May versus a revised $97.1 billion in the prior month.
    • Wholesale inventories fell 0.1% month-over-month in May versus a 0.3% decline in April.
    • US crude oil inventories dropped by 9.603 million barrels in the week ending June 23, versus market estimates of a 1.757 million decline.

    Now Read This: Kellogg To Rally Around 27%? Here Are 10 Other Analyst Forecasts For Tuesday

     

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 107,298,300 cases with around 1,168,040 deaths. India confirmed a total of at least 44,994,030 cases and 531,900 deaths, while France reported over 40,135,200 COVID-19 cases with 167,640 deaths. In total, there were at least 690,892,530 cases of COVID-19 worldwide with more than 6,895,110 deaths.

    Get the next $ASTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASTS
    $CGTX
    $KLR
    $NERV

    CompanyDatePrice TargetRatingAnalyst
    AST SpaceMobile Inc.
    $ASTS
    1/13/2026$105.00Buy → Neutral
    B. Riley Securities
    AST SpaceMobile Inc.
    $ASTS
    1/7/2026$45.60Sector Perform → Sector Underperform
    Scotiabank
    AST SpaceMobile Inc.
    $ASTS
    11/24/2025$45.60Sector Underperform → Sector Perform
    Scotiabank
    AST SpaceMobile Inc.
    $ASTS
    10/17/2025$60.00Overweight → Underweight
    Barclays
    AST SpaceMobile Inc.
    $ASTS
    10/7/2025Sector Perform → Sector Underperform
    Scotiabank
    AST SpaceMobile Inc.
    $ASTS
    9/9/2025$43.00Buy → Neutral
    UBS
    AST SpaceMobile Inc.
    $ASTS
    8/21/2025Mkt Perform
    William Blair
    AST SpaceMobile Inc.
    $ASTS
    6/25/2025$55.00Neutral
    BofA Securities
    More analyst ratings

    $ASTS
    $CGTX
    $KLR
    $NERV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AST SpaceMobile downgraded by B. Riley Securities with a new price target

    B. Riley Securities downgraded AST SpaceMobile from Buy to Neutral and set a new price target of $105.00

    1/13/26 9:00:28 AM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    AST SpaceMobile downgraded by Scotiabank with a new price target

    Scotiabank downgraded AST SpaceMobile from Sector Perform to Sector Underperform and set a new price target of $45.60

    1/7/26 8:53:24 AM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    AST SpaceMobile upgraded by Scotiabank with a new price target

    Scotiabank upgraded AST SpaceMobile from Sector Underperform to Sector Perform and set a new price target of $45.60

    11/24/25 8:38:18 AM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    $ASTS
    $CGTX
    $KLR
    $NERV
    SEC Filings

    View All

    SEC Form 424B5 filed by AST SpaceMobile Inc.

    424B5 - AST SpaceMobile, Inc. (0001780312) (Filer)

    2/11/26 5:13:12 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    SEC Form 424B5 filed by AST SpaceMobile Inc.

    424B5 - AST SpaceMobile, Inc. (0001780312) (Filer)

    2/11/26 5:10:51 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    AST SpaceMobile Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - AST SpaceMobile, Inc. (0001780312) (Filer)

    2/11/26 5:08:27 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    $ASTS
    $CGTX
    $KLR
    $NERV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AST SpaceMobile Announces Proposed Private Offering of $1.0 Billion of Convertible Senior Notes Due 2036

    Convertible Notes Offering AST SpaceMobile, Inc. ("AST SpaceMobile") (NASDAQ:ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, designed for both commercial and government applications, today announced its intent to offer, subject to market conditions and other factors, $1.0 billion aggregate principal amount of convertible senior notes due 2036 (the "Notes") in a private offering (the "Notes Offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). AST SpaceMobile also intends to grant the initial p

    2/11/26 4:55:00 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    AST SpaceMobile Announces Proposed Repurchases of up to $300.0 Million Convertible Senior Notes to be Funded By Concurrent Registered Direct Offerings of Class A Common Stock

    AST SpaceMobile, Inc. ("AST SpaceMobile") (NASDAQ:ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, and designed for both commercial and government applications, today announced proposed cash repurchases (the "Repurchases") of up to $50.0 million of its 4.25% convertible senior notes due 2032 (the "4.25% Convertible Notes") and up to $250.0 million of its 2.375% convertible senior notes due 2032 (the "2.375% Convertible Notes" and, together with the 4.25% Convertible Notes, the "Existing Notes") and its intention to offer, subject to market and other conditions, shares of its Class A common stock to holders of

    2/11/26 4:55:00 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    AST SpaceMobile Successfully Completes Unfolding of BlueBird 6, the Largest Commercial Communications Array Antenna Ever Deployed in Low Earth Orbit

    BlueBird 6 is the largest ever commercial communications array deployed in low Earth orbit, designed to support cellular broadband peak data speeds of up to 120 Mbps AST SpaceMobile, Inc. ("AST SpaceMobile") (NASDAQ:ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, designed for both commercial and government applications, today announced the successful unfolding of its next-generation BlueBird 6 satellite. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210108166/en/AST SpaceMobile 2,400 square feet phased array BlueBird 6 features the largest c

    2/10/26 8:14:00 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    $ASTS
    $CGTX
    $KLR
    $NERV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO & President Ricciardi Lisa was granted 800,000 shares and covered exercise/tax liability with 77,740 shares, increasing direct ownership by 73% to 1,712,526 units (SEC Form 4)

    4 - COGNITION THERAPEUTICS INC (0001455365) (Issuer)

    2/5/26 5:28:06 PM ET
    $CGTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Financial Officer Doyle John Brendan covered exercise/tax liability with 26,921 shares and was granted 200,000 shares, increasing direct ownership by 39% to 619,069 units (SEC Form 4)

    4 - COGNITION THERAPEUTICS INC (0001455365) (Issuer)

    2/5/26 5:27:19 PM ET
    $CGTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Medical Officer Caggiano Anthony was granted 400,000 shares and covered exercise/tax liability with 38,407 shares, increasing direct ownership by 71% to 869,586 units (SEC Form 4)

    4 - COGNITION THERAPEUTICS INC (0001455365) (Issuer)

    2/5/26 5:26:19 PM ET
    $CGTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ASTS
    $CGTX
    $KLR
    $NERV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Larson Keith R bought $50,000 worth of shares (625 units at $80.00) (SEC Form 4)

    4 - AST SpaceMobile, Inc. (0001780312) (Issuer)

    12/29/25 6:00:02 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    Director Larson Keith R bought $50,064 worth of shares (715 units at $70.02) (SEC Form 4)

    4 - AST SpaceMobile, Inc. (0001780312) (Issuer)

    12/17/25 6:00:10 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    Director Larson Keith R bought $49,079 worth of shares (675 units at $72.71) (SEC Form 4)

    4 - AST SpaceMobile, Inc. (0001780312) (Issuer)

    12/10/25 6:00:21 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    $ASTS
    $CGTX
    $KLR
    $NERV
    Leadership Updates

    Live Leadership Updates

    View All

    Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company's Board of Directors

    BURLINGTON, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced the appointment of Dr. Inderjit Kaul, Chief Medical Officer of Draig Therapeutics, to the board of directors. Dr. Kaul will also serve as a consultant to the Company for the future clinical development of roluperidone. Last month, the Company announced successfully raising up to $200 million in a private placement to fund a confirmatory Phase 3 trial for roluperidone for the treatment of negative symptoms in patients with schizophrenia, resubmission of it

    11/19/25 8:30:00 AM ET
    $NERV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AST SpaceMobile Set to Join the U.S. Large-Cap Russell 1000® Index

    Membership recognizes AST SpaceMobile as one of the largest 1,000 U.S. companies by market capitalization AST SpaceMobile, Inc. ("AST SpaceMobile") (NASDAQ:ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, designed for both commercial and government applications, today announced it is set to join the U.S. large-cap Russell 1000® Index, effective after the U.S. market closes on June 27, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250610443528/en/AST SpaceMobile is Set to Join the U.S. Large-Cap

    6/10/25 7:30:00 AM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D.

    PRINCETON, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs targeted to the tumor microenvironment (TME), today announced with deep and profound sadness the tragic passing of Pankaj Mohan, Ph.D., Sonnet Founder and Chief Executive Officer. The Company's Board of Directors has unanimously approved the appointment of current board member Raghu Rao, as Interim Chief Executive Officer of the Company, and the promotion of Stephen McAndrew, Ph.D., the Company's current Chief Business Officer, to President and Chief Business Officer of the Company. The Board intends

    4/1/25 7:30:00 AM ET
    $SONN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASTS
    $CGTX
    $KLR
    $NERV
    Financials

    Live finance-specific insights

    View All

    Defiance ETFs Launches ASTN: The First 2X Short ETF of AST SpaceMobile Inc.

    MIAMI, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs is proud to announce the launch of the Defiance Daily Target 2X Short ASTS ETF (Ticker: ASTN), expanding its lineup of innovative single-stock leveraged ETFs designed for sophisticated traders seeking precision tools for short-term market expression. Investment Objective The Fund seeks daily inverse investment results, before fees and expenses, of -2 times (-200%) the daily percentage change in the share price of AST SpaceMobile, Inc. (NASDAQ:ASTS). The Fund does not seek to achieve its stated investment objective for a period other than a single trading day. Underlying Stock: AST SpaceMobile Inc. AST SpaceMobile, Inc. is developin

    2/6/26 8:31:00 AM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    Cognition Therapeutics to Participate in 37th Annual Piper Sandler Healthcare Conference

    PURCHASE, N.Y., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ:CGTX), a clinical stage company developing product candidates designed to treat neurodegenerative disorders, announced that the Company's president and CEO, Lisa Ricciardi will participate in an "unplugged" fireside discussion at the annual Piper Sandler Healthcare Conference. The conference will take place December 2-4, 2025 at The Lotte New York Palace hotel. Details of Cognition's fireside discussion are as follows: Event: 37th Annual Piper Sandler Healthcare Conference   Date/Time: Wednesday, December 3rd at 4:30p.m. Eastern Time Webcast: https://event.webcasts.com/starthere.jsp?ei=1742473&tp_key=11

    11/20/25 4:01:00 PM ET
    $CGTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Cognition Therapeutics Completes Enrollment in Phase 2 Study of Zervimesine (CT1812) in Early Alzheimer's Disease

    PURCHASE, N.Y., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ:CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, announced that the company has reached target enrollment of 540 participants in the randomized, placebo-controlled Phase 2 ‘START' Study. A number of additional patients are in the final stages of screening and will be randomized if they meet all eligibility requirements. START will assess the safety and activity of zervimesine (CT1812) in participants with mild cognitive impairment (MCI) or early Alzheimer's disease. Topline results are expected after all participants have completed 18 mo

    11/13/25 7:36:19 AM ET
    $CGTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ASTS
    $CGTX
    $KLR
    $NERV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by AST SpaceMobile Inc.

    SC 13D/A - AST SpaceMobile, Inc. (0001780312) (Subject)

    11/20/24 9:59:14 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by AST SpaceMobile Inc.

    SC 13G/A - AST SpaceMobile, Inc. (0001780312) (Subject)

    11/12/24 1:30:47 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Minerva Neurosciences Inc

    SC 13G/A - Minerva Neurosciences, Inc. (0001598646) (Subject)

    11/12/24 10:32:12 AM ET
    $NERV
    Biotechnology: Pharmaceutical Preparations
    Health Care